FM
FOLD

Frazier Management’s Amicus Therapeutics FOLD Stock Holding History

Frazier Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,600,014
Closed -$40.6M – 17
2018
Q2 		$40.6M Hold
2,600,014
– – 8.41% 5
2018
Q1 		$39.1M Hold
2,600,014
– – 6.49% 3
2017
Q4 		$37.4M Hold
2,600,014
– – 6.07% 3
2017
Q3 		$39.2M Hold
2,600,014
– – 13.98% 2
2017
Q2 		$26.2M Hold
2,600,014
– – 13.42% 2
2017
Q1 		$18.5M Hold
2,600,014
– – 9.9% 3
2016
Q4 		$12.9M Hold
2,600,014
– – 16.26% 4
2016
Q3 		$19.2M Sell
2,600,014
-125,577
-5% -$848K 9.44% 3
2016
Q2 		$14.9M Sell
2,725,591
-192,700
-7% -$1.35M 11.87% 4
2016
Q1 		$24.7M Hold
2,918,291
– – 15.18% 3
2015
Q4 		$28.3M Buy
+2,918,291
New +$26.3M 11.84% 4

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Frazier Management's FOLD Position: Q3 2018 in Review

Frazier Management sold out of Amicus Therapeutics (FOLD) in Q3 2018, closing a stake of 2,600,014 shares — an estimated $40.6M sold.

Frazier Management first reported a position in FOLD in Q4 2015 and held it in 11 quarters. The position peaked at $40.6M in Q2 2018. 204 funds tracked by Wall St. Rank hold FOLD as of Q3 2018.

  • Frazier Management reported no remaining Amicus Therapeutics position as of Q3 2018 after selling out during the quarter.
  • Frazier Management sold 2,600,014 Amicus Therapeutics shares in Q3 2018, an estimated $40.6M.
  • Frazier Management first reported a position in Amicus Therapeutics in Q4 2015 and held it in 11 quarters.
  • Frazier Management's Amicus Therapeutics position peaked at $40.6M in Q2 2018.
  • 204 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2018.

Based on Frazier Management's 13F filing for Q3 2018, filed 14 Nov 2018.